Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 72 articles:
HTML format



Single Articles


    January 2021
  1. JUNG JM, Na HM, Won CH, Chang SE, et al
    Cutaneous Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma, not otherwise specified: A systematic review and comparative analysis with Epstein-Barr Virus-negative, leg type.
    J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00248.
    PubMed    


  2. JU HJ, Han JH, Kim MS, Lee SH, et al
    The long-term risk of lymphoma and skin cancer was not increased after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
    J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00224.
    PubMed     Abstract available


  3. MALACHOWSKI SJ, Moy A, Messina J, Chen YA, et al
    Mapping Cutaneous T-Cell Lymphoma in the State of Florida: a Retrospective Exploratory Spatial Analysis of Incidence Patterns.
    J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00190.
    PubMed    


    December 2020
  4. WEINER DM, Durgin JS, Wysocka M, Rook AH, et al
    The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part II, Current and Future Approaches.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33186.
    PubMed     Abstract available


  5. DURGIN JS, Weiner DM, Wysocka M, Rook AH, et al
    The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33187.
    PubMed     Abstract available


  6. RAMACHANDRAN V, Park KE, Loya A, Duvic M, et al
    Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: A national database study.
    J Am Acad Dermatol. 2020;83:1786-1789.
    PubMed    


    November 2020
  7. SCHACHTER O, Tabibian-Keissar H, Debby A, Segal O, et al
    Evaluation of the polymerase chain reaction-based T-cell receptor beta clonality test in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2020;83:1400-1405.
    PubMed     Abstract available


    August 2020
  8. GOYAL A, O'Leary D, Goyal K, Patel K, et al
    Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32444.
    PubMed     Abstract available


  9. GELLER S, Lebowitz E, Pulitzer MP, Horwitz SM, et al
    Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sezary syndrome: Retrospective analysis of 157 patients from a referral cancer center.
    J Am Acad Dermatol. 2020;83:430-439.
    PubMed     Abstract available


  10. GOYAL A, O'Leary D, Goyal K, Rubin N, et al
    Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
    J Am Acad Dermatol. 2020;83:404-411.
    PubMed     Abstract available


  11. ALMUKHTAR R, Gill F, Soine R, McBurney E, et al
    Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and Sezary syndrome.
    J Am Acad Dermatol. 2020;83:647-648.
    PubMed    


    July 2020
  12. MUNIESA C, Domingo-Domenech E, Fornons-Servent R, Penate Y, et al
    SYSTEMIC RITUXIMAB FOR THE TREATMENT OF THE INDOLENT FORMS OF PRIMARY CUTANEOUS B-CELL LYMPHOMAS: data from the Spanish Primary Cutaneous Lymphoma Registry.
    J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32192.
    PubMed    


  13. SONG A, Gochoco A, Zhan T, Sahu J, et al
    A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
    J Am Acad Dermatol. 2020;83:78-85.
    PubMed     Abstract available


    May 2020
  14. ELLIS A, Christensen LF, Sharma T, Meyerson H, et al
    CD30 positive Leukemic Cutaneous T Cell Lymphoma.
    J Am Acad Dermatol. 2020 May 10. pii: S0190-9622(20)30841.
    PubMed    


  15. LAKE E
    JAAD Game Changers*: Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study.
    J Am Acad Dermatol. 2020;82:1274.
    PubMed    


    April 2020
  16. GAO C, McCormack CJ, van der Weyden C, Twigger R, et al
    The importance of differentiating between Mycosis Fungoides with CD30 positive large cell transformation and Mycosis Fungoides with co-existent primary cutaneous Anaplastic Large Cell Lymphoma.
    J Am Acad Dermatol. 2020 Apr 22. pii: S0190-9622(20)30688.
    PubMed    


  17. ZIC JA, Ai W, Akilov OE, Carter JB, et al
    (United States Cutaneous Lymphoma Consortium) Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic.
    J Am Acad Dermatol. 2020 Apr 16. pii: S0190-9622(20)30662.
    PubMed    


  18. YUKI A, Ansai O, Abe R
    CADM1 expression of mast cells in mycosis fungoides.
    J Am Acad Dermatol. 2020;82:e143-e144.
    PubMed    


  19. ZHANG S, Wang T, Liu Y
    CADM1: A molecule worth investigating in mycosis fungoides and Sezary syndrome.
    J Am Acad Dermatol. 2020;82:e141-e142.
    PubMed    


    March 2020
  20. ELSTON DM
    Letter from the editor: Dupilumab and Cutaneous T-cell Lymphoma.
    J Am Acad Dermatol. 2020 Mar 27. pii: S0190-9622(20)30471.
    PubMed    


  21. ESPINOSA ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, et al
    Progression of Cutaneous T-Cell Lymphoma after dupilumab: Case review of 7 patients.
    J Am Acad Dermatol. 2020 Mar 27. pii: S0190-9622(20)30470.
    PubMed    


  22. DELOST GR, Giesey RL, Christensen LF, Scott J, et al
    Cutaneous lymphomas in adolescents and young adults: Clinical spectrum and physician-reported and patient-reported outcomes.
    J Am Acad Dermatol. 2020;82:751-753.
    PubMed    


  23. GOYAL A, O'Leary D, Goyal K, Rubin N, et al
    Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study.
    J Am Acad Dermatol. 2020;82:736-738.
    PubMed    


    February 2020
  24. KIM EJ, Geskin L, Guitart J, Querfeld C, et al
    Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
    J Am Acad Dermatol. 2020 Feb 20. pii: S0190-9622(20)30057.
    PubMed    


    January 2020
  25. BONTOUX C, De Masson A, Boccara O, Bodemer C, et al
    Outcome And Clinico-Phenotypical Features Of Acute Lymphoblastic Leukemia/Lymphoma With Cutaneous Involvement: A Multicentric Case-Series.
    J Am Acad Dermatol. 2020 Jan 30. pii: S0190-9622(20)30142.
    PubMed    


  26. PAVLOTSKY F, Hodak E, Dawood M, Barzilai A, et al
    Stage IA mycosis fungoides should be treated until proven otherwise.
    J Am Acad Dermatol. 2020;82:e19-e20.
    PubMed    


  27. BISHNOI A, Kumar S, Vinay K
    Stage IA mycosis fungoides: When not to treat?
    J Am Acad Dermatol. 2020;82:e17-e18.
    PubMed    


  28. FLAMM A, Alcocer VM, Kazlouskaya V, Kwon EJ, et al
    Histopathologic features distinguishing secondary syphilis from its mimickers.
    J Am Acad Dermatol. 2020;82:156-160.
    PubMed     Abstract available


    November 2019
  29. JAIN M, Goyal K, O'Leary D, Rubin N, et al
    Improved survival for skin-primary presentation of adult T-cell leukemia/lymphoma (ATLL).
    J Am Acad Dermatol. 2019 Nov 22. pii: S0190-9622(19)33126.
    PubMed    


  30. XUE R, Elbendary A, Liu H, Chen Y, et al
    Hydroa vacciniforme-like lymphoma: clinicopathological description, treatment and outcome.
    J Am Acad Dermatol. 2019 Nov 20. pii: S0190-9622(19)33122.
    PubMed    


  31. DESTEFANO CB, Desale S, Fernandez SJ, Shenoy AG, et al
    The impact of environmental ultraviolet exposure on the clinical course of mycosis fungoides.
    J Am Acad Dermatol. 2019;81:1074-1077.
    PubMed     Abstract available


    September 2019
  32. ROZENBAUM D, Tung J, Xue Y, Hoang MP, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: a retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2019 Sep 18. pii: S0190-9622(19)32752.
    PubMed     Abstract available


  33. ERRICHETTI E, Durdu M
    Reply: Application of dermoscopy in folliculotropic mycosis fungoides.
    J Am Acad Dermatol. 2019;81:e77-e78.
    PubMed    


  34. GELLER S, Rishpon A, Myskowski PL
    Dermoscopy in folliculotropic mycosis fungoides-A possible mimicker of follicle-based inflammatory and infectious disorders.
    J Am Acad Dermatol. 2019;81:e75-e76.
    PubMed    


    July 2019
  35. KING BJ, Lester SC, Tolkachjov SN, Davis MD, et al
    Skin Directed Radiation Therapy for Cutaneous Lymphoma: The Mayo Clinic Experience.
    J Am Acad Dermatol. 2019 Jul 22. pii: S0190-9622(19)32423.
    PubMed     Abstract available


  36. WARE O, Tarabadkar ES, Shustov A, Shinohara MM, et al
    Pralatrexate for refractory or recurrent subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome.
    J Am Acad Dermatol. 2019 Jul 15. pii: S0190-9622(19)32379.
    PubMed    


    June 2019
  37. HEYMANN WR
    Predicting the nature of follicular mucinosis: Still a sticky situation.
    J Am Acad Dermatol. 2019;80:1524-1525.
    PubMed    


  38. OUEDRAOGO E, Gottlieb J, de Masson A, Lepelletier C, et al
    Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.
    J Am Acad Dermatol. 2019;80:1544-1549.
    PubMed     Abstract available


  39. GELLER S, Gomez CJ, Myskowski PL, Pulitzer M, et al
    Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study.
    J Am Acad Dermatol. 2019;80:1704-1711.
    PubMed     Abstract available


  40. LAKE E
    JAAD Game Changers: Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study.
    J Am Acad Dermatol. 2019;80:1815.
    PubMed    


  41. PAVLOTSKY F, Dawood M, Barzilai A
    Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides.
    J Am Acad Dermatol. 2019;80:1550-1555.
    PubMed     Abstract available


    May 2019
  42. SALEEM MD, Oussedik E, Picardo M, Schoch JJ, et al
    Acquired disorders with hypopigmentation: A clinical approach to diagnosis and treatment.
    J Am Acad Dermatol. 2019;80:1233-1250.
    PubMed     Abstract available


    February 2019
  43. XIA FD, Ferket BS, Huang V, Stern RS, et al
    Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States.
    J Am Acad Dermatol. 2019;80:485-492.
    PubMed     Abstract available


    January 2019
  44. KHETERPAL MK, Dai J, Geller S, Pulitzer M, et al
    Role of imaging in low grade cutaneous B-cell lymphoma presenting in the skin.
    J Am Acad Dermatol. 2019 Jan 28. pii: S0190-9622(19)30144.
    PubMed     Abstract available


  45. GELLER S, Navarrete-Dechent C, Myskowski PL
    Dermoscopy in lymphoproliferative disorders - experience from a cutaneous lymphoma clinic in a tertiary cancer center.
    J Am Acad Dermatol. 2019 Jan 14. pii: S0190-9622(19)30074.
    PubMed    


    December 2018
  46. YUKI A, Shinkuma S, Hayashi R, Fujikawa H, et al
    CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
    J Am Acad Dermatol. 2018;79:1039-1046.
    PubMed     Abstract available


    November 2018
  47. OH SJ, Park JH, Lee JH, Lee DY, et al
    Cutaneous extranodal natural killer/T-cell lymphoma: Clinical implications of whole blood Epstein-Barr virus DNA.
    J Am Acad Dermatol. 2018 Nov 28. pii: S0190-9622(18)32957.
    PubMed    


  48. DAMASCO FM, Geskin L, Akilov OE
    Onychodystrophy in Sezary syndrome.
    J Am Acad Dermatol. 2018;79:972-973.
    PubMed    


    October 2018
  49. WANG J, Rea B, Haun P, Emerson R, et al
    High-Throughput Sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma.
    J Am Acad Dermatol. 2018 Oct 23. pii: S0190-9622(18)32761.
    PubMed    


  50. LEE MH, Choi ME, Won CH, Chang SE, et al
    Comparative Clinicopathological Analysis of Cutaneous Peripheral T-cell lymphoma, Not Otherwise Specified, According to Primary Tumor Site.
    J Am Acad Dermatol. 2018 Oct 5. pii: S0190-9622(18)32663.
    PubMed    


    September 2018
  51. LEE WJ, Won KH, Choi JW, Won CH, et al
    Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr Virus positivity and its effects on clinicopathological features.
    J Am Acad Dermatol. 2018 Sep 18. pii: S0190-9622(18)32586.
    PubMed     Abstract available


  52. STEINKE S, Zeidler C, Riepe C, Bruland P, et al
    Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
    J Am Acad Dermatol. 2018;79:457-463.
    PubMed     Abstract available


    August 2018
  53. LOPEZ-LERMA I, Penate Y, Gallardo F, Marti RM, et al
    Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.
    J Am Acad Dermatol. 2018 Aug 17. pii: S0190-9622(18)32048.
    PubMed     Abstract available


  54. GOYAL A, Goyal K, Bohjanen K
    Mortality in intravascular large B-cell lymphoma: A SEER analysis.
    J Am Acad Dermatol. 2018 Aug 6. pii: S0190-9622(18)32344.
    PubMed    


    June 2018
  55. LINDAHL LM, Schmidt M, Farkas DK, Sorensen HT, et al
    Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study.
    J Am Acad Dermatol. 2018;78:1077-1083.
    PubMed     Abstract available


  56. KRIDIN K, Zelber-Sagi S, Comaneshter D, Batat E, et al
    Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
    J Am Acad Dermatol. 2018;78:1084-1089.
    PubMed     Abstract available


    May 2018
  57. YUAN Z, Grass GD, Robinson TJ, Kim S, et al
    Management of primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A retrospective study.
    J Am Acad Dermatol. 2018 May 29. pii: S0190-9622(18)30829.
    PubMed    


    March 2018
  58. PAIK SH, Kim YJ, Won CH, Chang SE, et al
    Cutaneous posttransplantation lymphoma: clinical features and survival outcomes.
    J Am Acad Dermatol. 2018 Mar 17. pii: S0190-9622(18)30459.
    PubMed    


  59. NA SJ, Kang MJ, Yu DS, Han KD, et al
    Cancer risk in patients with Behcet disease: A nationwide population-based dynamic cohort study from Korea.
    J Am Acad Dermatol. 2018;78:464-470.
    PubMed     Abstract available


    February 2018
  60. GOYAL A, Carter JB, Pashtan I, Gallotto S, et al
    Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study.
    J Am Acad Dermatol. 2018;78:408-410.
    PubMed    


    January 2018
  61. MARTINEZ-ESCALA ME, Posligua AL, Wickless H, Rutherford A, et al
    Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy.
    J Am Acad Dermatol. 2018 Jan 4. pii: S0190-9622(18)30010.
    PubMed     Abstract available


    November 2017
  62. WARREN S, Kheterpal M, Myskowski PL, Moskowitz A, et al
    Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.
    J Am Acad Dermatol. 2017 Nov 10. pii: S0190-9622(17)32339.
    PubMed     Abstract available


    October 2017
  63. MANGOLD AR, Thompson AK, Davis MD, Saulite I, et al
    Early clinical manifestations of Sezary syndrome: A multicenter retrospective cohort study.
    J Am Acad Dermatol. 2017;77:719-727.
    PubMed     Abstract available


    September 2017
  64. MARTINEZ-ESCALA ME, Kantor RW, Cices A, Zhou XA, et al
    CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder.
    J Am Acad Dermatol. 2017;77:489-496.
    PubMed     Abstract available


  65. SU C, Nguyen KA, Bai HX, Cao Y, et al
    Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database.
    J Am Acad Dermatol. 2017;77:497-502.
    PubMed     Abstract available


    August 2017
  66. GU Y, Nordstrom BL
    The risk of malignancy among biologic-naive pediatric psoriasis patients: A retrospective cohort study in a US claims database.
    J Am Acad Dermatol. 2017;77:293-301.
    PubMed     Abstract available


    April 2017
  67. THOMPSON AK, Killian JM, Weaver AL, Pittelkow MR, et al
    Sezary syndrome without erythroderma: A review of 16 cases at Mayo Clinic.
    J Am Acad Dermatol. 2017;76:683-688.
    PubMed     Abstract available


  68. LEVY JM, Magro C
    Atrophying pityriasis versicolor as an idiosyncratic T cell-mediated response to Malassezia: A case series.
    J Am Acad Dermatol. 2017;76:730-735.
    PubMed     Abstract available


    March 2017
  69. SALEEM MD, Kesty C, Feldman SR
    Relative versus absolute risk of comorbidities in patients with psoriasis.
    J Am Acad Dermatol. 2017;76:531-537.
    PubMed     Abstract available


    November 2016
  70. LEMCHAK DM, Akilov OE
    Interleukin-12 immunohistochemistry as a diagnostic tool for patch-stage mycosis fungoides.
    J Am Acad Dermatol. 2016;75:1053-1054.
    PubMed    


    August 2016
  71. HODAK E, Amitay-Laish I, Atzmony L, Prag-Naveh H, et al
    New insights into folliculotropic mycosis fungoides (FMF): A single-center experience.
    J Am Acad Dermatol. 2016;75:347-55.
    PubMed     Abstract available


    July 2016
  72. DUNCAN JR, Carr D, Kaffenberger BH
    The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer.
    J Am Acad Dermatol. 2016;75:186-96.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: